• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS FREE PSA; TEST,PROSTATE SPECIFIC ANTIGEN,FREE,(NONCOMPLEXED) TO DISTINGUISH PROSTATE CA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS FREE PSA; TEST,PROSTATE SPECIFIC ANTIGEN,FREE,(NONCOMPLEXED) TO DISTINGUISH PROSTATE CA Back to Search Results
Catalog Number 03289788190
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 02/16/2018
Event Type  malfunction  
Manufacturer Narrative
The event occurred in: (b)(6).(b)(4).
 
Event Description
The customer complained of a possible interference for 1 patient when tested for elecsys free psa immunoassay on a cobas 6000 e 601 module compared to the patient's elecsys total psa immunoassay results.The customer provided three separate incidents where the patient's free psa values were higher than their total psa results.This medwatch will cover the free psa data.Please refer to the medwatch with patient identifier (b)(6) for data on the total psa.On (b)(6) 2018 the free psa result was 0.78 ng/ml with a total psa result of 0.11 ng/ml.On (b)(6) 2018 the free psa result was 0.61 ng/ml with a total psa result of 0.12 ng/ml.On (b)(6) 2018 the free psa result was 0.51 ng/ml with a total psa result of 0.13 ng/ml.It was only provided that the results from (b)(6) 2018 were released outside of the laboratory.There was no allegation of any adverse events.The only free psa and total psa reagent lot information provided was for the results obtained on (b)(6) 2018.The cobas e602 used for the (b)(6) 2018 results was 26c2-11.The investigation showed that the calibration and qc data that was provided was acceptable.On the day of the (b)(6) 2018 measurements, there was no qc testing performed.The customer provided the patient sample from (b)(6) 2018 for further investigation.The investigation is currently ongoing.
 
Manufacturer Narrative
The free psa reagent lot was 293436, with an expiration date of 30-april-2019.Calibration data for free psa was acceptable.Qc recovery was within the specified ranges.The sample was tested on a roche analyzer and on a competitor analyzer at an external laboratory for investigation.The customer¿s results were confirmed.The investigation results are consistent with the presence of an interferent.This interference is documented in product labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREE PSA
Type of Device
TEST,PROSTATE SPECIFIC ANTIGEN,FREE,(NONCOMPLEXED) TO DISTINGUISH PROSTATE CA
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key8004050
MDR Text Key126239652
Report Number1823260-2018-03824
Device Sequence Number1
Product Code MTG
Combination Product (y/n)N
PMA/PMN Number
P000027
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 11/21/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2019
Device Catalogue Number03289788190
Device Lot Number293436
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 10/05/2018
Initial Date FDA Received10/25/2018
Supplement Dates Manufacturer Received10/05/2018
Supplement Dates FDA Received11/21/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age55 YR
-
-